Russell Medford
Director/Board Member chez THERMOGENESIS HOLDINGS, INC.
Fortune : - $ au 31/03/2024
Profil
Russell M.
Medford founded AtheroGenics, Inc. in 1993, where he worked as President, Chief Executive Officer & Director from 1993 to 2009 and Covanos, Inc. in 2014, where he is working as Chairman & Chief Executive Officer from 2017.
Dr. Medford also currently works at Salutria Pharmaceuticals, Inc., as Chairman & President from 2009, Atlantic Therapeutics Ltd., as Chairman from 2022, Viamune, Inc., as Executive Chairman from 2014, OncoSpherix, Inc., as Chairman, ThermoGenesis Holdings, Inc., as Independent Director from 2017, Georgia Institute of Technology, as Director-Global Centre for Medical Innovation, Southeast BIO, as Director, and Salutramed Group LLC, as Managing Partner from 2012.
Dr. Medford also formerly worked at Healthegames, Inc., as Chief Executive Officer, Center for Global Health Innovation, Inc., as Chairman, Inhibitex LLC, as Independent Director from 2011 to 2012, Biotechnology Innovation Organization, as Director from 2002 to 2014, and Georgia Global Health Alliance, Inc., as Director from 2016 to 2020.
Dr. Medford received his undergraduate degree from Cornell University, doctorate degree from Yeshiva University, and doctorate degree from Albert Einstein College of Medicine, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/10/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Russell Medford
| Sociétés | Poste | Début |
|---|---|---|
| THERMOGENESIS HOLDINGS, INC. | Director/Board Member | 24/02/2017 |
| OncoSpherix, Inc. | Chairman | - |
| Georgia Institute of Technology | Corporate Officer/Principal | - |
Covanos, Inc.
 Covanos, Inc. Packaged SoftwareTechnology Services Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014. | Chief Executive Officer | 01/01/2014 |
| Salutramed Group LLC | Corporate Officer/Principal | 01/01/2012 |
| Viamune, Inc. | Chairman | 01/01/2014 |
Salutria Pharmaceuticals, Inc.
 Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Chairman | 06/05/2010 |
| Southeast BIO | Director/Board Member | - |
Atlantic Therapeutics Ltd.
 Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Atlantic Therapeutics Ltd. is a medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products. The firm offers INNOVO products. The company is headquartered in Galway, Ireland. | Chairman | 27/07/2022 |
Anciens postes connus de Russell Medford
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Formation de Russell Medford
| Cornell University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| THERMOGENESIS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Healthegames, Inc.
 Healthegames, Inc. Miscellaneous Commercial ServicesCommercial Services Healthegames, Inc. provides public relations and communications services. The private company is based in Atlanta, GA. | Commercial Services |
Center for Global Health Innovation, Inc.
 Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Health Technology |
| Southeast BIO | |
Salutria Pharmaceuticals, Inc.
Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Retail Trade |
Atlantic Therapeutics Ltd.
Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Atlantic Therapeutics Ltd. is a medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products. The firm offers INNOVO products. The company is headquartered in Galway, Ireland. | Health Technology |
| Viamune, Inc. | |
| Georgia Global Health Alliance, Inc. | |
| Salutramed Group LLC | |
Covanos, Inc.
Covanos, Inc. Packaged SoftwareTechnology Services Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014. | Technology Services |
| OncoSpherix, Inc. |
